Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

First Human Stem Cell Trials Planned

Posted by Jane Akre
Friday, January 23, 2009 12:00 PM EST
Category: Major Medical, Protecting Your Family
Tags: Stem Cell Therapy, Geron Corp., Embryonic Cells, Bush Administration, FDA and Prescription Drugs

Trials will begin this summer on human embryonic stem cells directed at paralysis



IMAGE SOURCE: Wikimedia commons/ Embryonic stem cells/ author: Nissim Benvenisty


Three days after the inauguration of President Barack Obama, the green light has been given for the first study of human embryonic stem cell therapy testing. 

The Food and Drug Administration (FDA) gave the okay for the research on Friday, with allows Geron Corp., a biotech company in Menlo Park California, to test its product that will focus on reversing paralysis from spinal cord injuries.  

The eight to 10 patients in the trial will be those recently injured with severe spinal cord injuries and no hope of recovery below the injury. Nerve cells will be injected directly into the injury site. Geron says the patients will be monitored for a year to see if they regain any function. So far research has restored some movement to paralyzed rats. 

The trials should begin this summer.

Embryonic stem cell lines are able to turn into any one of the body’s 200 cell types, but there are only about 60 stem cells lines that remain viable created from embryos that were destroyed prior to August 2001, according to BBC News.  The cell lines can be grown indefinitely.

Company chief, Dr. Tom Okarma said: "What stem cells promise for a heart attack or spinal cord injury or diabetes is that you go to the hospital, you receive these cells and you go home with a repaired organ, that has been repaired by new heart cells or new nerve cells or new islet cells that have been made from embryonic stem cells."

Okarma said that Geron did not use federal funding for its research but spent about $45 million of its own money.  The company says it has seven types of cell lines in its pipeline.   Okarma  tells CNN that Bush restrictions had “devastated the field.” 

President Bush approved funding research for those cell lines already in existence before August 2001. Fewer than two dozen have proven useful for research.   Abortion opponents oppose lifting the funding restrictions.

Hopes are the stem cell lines might be able to address Alzheimer’s, Parkinson’s, and diabetes. Ending the current restrictions on federally funded stem-cell research was at the top of an Obama agenda on medical issues. Chief of Staff Rahm Emanuel said the approach would be "pragmatic and progressive”.

Though he could issue an executive order to reverse the prohibition, Mr. Obama has indicated he may let Congress take the lead on that issue.

Upon the news, Geron shares surged 25 percent. #  

No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address


RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes